NARA Discovery
Article Details
← Back to Search Results
Journal Article

Phenotypic and genotypic resistance to colistin in E. coli isolated from wild boar (Sus scrofa) hunted in Italy

Giovanni Cilia; Barbara Turchi; Filippo Fratini; Valentina Virginia Ebani; Luca Turini; Domenico Cerri; Fabrizio Bertelloni
European Journal of Wildlife Research · Vol. 67, Issue 3 · 2021

Abstract

The One Health approach is not only focused on diseases and zoonosis control but also on antimicrobial resistance. As concern this important issue, the problem of plasmid-mediated colistin resistance recently emerged. Few studies reported data about colistin resistance and mcr genes in bacteria from wildlife. In this manuscript, 168 Escherichia coli isolated from hunted wild boar were tested; colistin resistance was evaluated by MIC microdilution method, and the presence of mcr-1 and mcr-2 genes was evaluated by PCR. Overall, 27.9% of isolates resulted resistant to colistin, and most of them showed a MIC value > 256 μg/mL. A percentage of 44.6% of tested E. coli scored positive for one or both genes. In details, 13.6% of isolated harbored mcr-1 and mcr-2 in combination; most of them exhibiting the highest MIC values. Interestingly, 19.6% of mcr -positive E. coli resulted phenotypically susceptible to colistin. Wild boar could be considered a potential reservoir of colistin-resistant bacteria. In the light of the possible contacts with domestic animals and humans, this wild species could play an important role in the diffusion of colistin resistance. Thus, the monitoring programs on wildlife should include this aspect.

Bibliographic Information

JournalEuropean Journal of Wildlife Research
PublisherSpringer
Publication Date2021-06-01
Publication Year2021
Volume67
Issue3
Document TypeJournal Article
Print ISSN1612-4642
eISSN1439-0574
DOI10.1007/s10344-021-01501-6

Access Information

NARA Access Coverage1955-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10344
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.